AVGO: $339 Valuation Check as Oil Risk Looms

Let's start with what you're paying. At $339.14, Broadcom trades at a trailing P/E of 71.25, a price-to-book of 19.65, and an EV/EBITDA of 149.68. These are not value metrics by any stretch. They're growth-at-any-price metrics, and they demand that Broadcom deliver flawless execution for years.

The bull case rests on forward earnings normalization. Consensus estimates peg FY2028 EPS at roughly $5.40-$6.00, which would compress the forward P/E to around 57-63x on today's price. That's still expensive, but it's in the ballpark for a company growing revenue at 20%+ annually with dominant market share in AI networking.

The debt picture adds another wrinkle. Broadcom carries a debt-to-equity ratio of 0.827 — manageable for a company generating $1.69 per share in free cash flow with a 97% FCF conversion rate and 33x capex coverage. But in a rising rate environment triggered by an oil shock, refinancing that debt becomes incrementally more expensive.

The dividend yield at 0.197% with a 42% payout ratio tells you this isn't an income stock. You're buying AVGO purely for capital appreciation, which means valuation compression is your primary downside risk.

Broadcom's revenue trajectory over the past four quarters tells a compelling growth story:

From $15 billion in Q2 FY2025 to $19.31 billion in Q1 FY2026, that's a 29% increase in three quarters. The sequential acceleration from Q4 to Q1 — $18.02 billion to $19.31 billion — represents 7.2% quarter-over-quarter growth, driven almost entirely by AI networking chip demand from hyperscale cloud customers.

But here's the rub: this acceleration is already embedded in the stock price. AVGO has more than doubled from its 52-week low of $138.10. The market isn't discovering Broadcom's AI story — it's paying a full premium for it. The incremental buyer at $339 needs to believe that revenue growth will exceed current consensus expectations of $47-52 billion by FY2028, not merely meet them.

Q1 FY2026 delivered $7.35 billion in net income on $19.31 billion in revenue, translating to a 38.1% net margin. Gross margins came in at 65.6%. Both are strong numbers, but they represent a step down from Q4 FY2025's performance.

The Q4 FY2025 EPS of $1.74 included favorable one-time items that inflated the number. Q1's $1.50 diluted EPS is a cleaner read on the business, and it represents genuine earnings power. Still, the sequential decline from $1.74 to $1.50 may give momentum investors pause.

Return on equity at 9.2% looks underwhelming for a $1.61 trillion company, but this reflects Broadcom's large goodwill base from the VMware acquisition. Strip out acquisition-related intangibles, and the underlying return on invested capital is considerably higher. The 97% free cash flow conversion rate confirms that Broadcom's earnings are overwhelmingly cash-based — not an accounting fiction.

Morgan Stanley's recent note flagged that "$150 oil won't hurt Broadcom's business but could hurt the stock." This is the most important distinction for investors to understand right now.

Broadcom's direct exposure to oil prices is negligible. The company designs chips and software — it doesn't operate container ships or run aluminum smelters. Its hyperscaler customers (Google, Meta, Microsoft, Amazon) have locked in multi-year AI infrastructure budgets that won't be derailed by a single commodity spike.

But markets don't trade on fundamentals alone. A sustained move above $130 in crude would likely trigger inflation fears, push the 10-year Treasury yield higher, and compress equity multiples across the board. Growth stocks with elevated P/E ratios get hit hardest in this scenario — and at 71x earnings, AVGO sits squarely in the crosshairs.

Historically, when oil spikes have coincided with Fed tightening (or a pause in loosening), high-multiple tech stocks have corrected 15-25% even when their earnings were unaffected. Broadcom's business would likely continue growing through an oil shock, but you might get to buy that growth at 50-55x earnings instead of 71x. That's a $250-$270 stock on the same fundamentals.

This isn't a reason to panic-sell, but it's a reason to size positions carefully and consider whether full exposure at $339 is optimal risk management.